Leishmania donovani infection of human myeloid dendritic cells leads to a Th1 response in CD4+ T cells from healthy donors and patients with Kala-Azar

Journal of Infectious Diseases

Volumn 194, Issue 3, 2006, Pages 294-301

  Ghosh, Monidipa ^a   Mandal, Labanya ^a   Maitra, Sudipta ^a   Rakshit, Srabanti ^a   Paul, Kausik ^a   Bagchi, Jayashree ^a   Ganguly, Dipyaman ^a   Pal, Chiranjib ^a,b   Bandyopadhyay, Santu ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b BKC College   (India)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; BETA ACTIN; CD209 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND MONOCLONAL ANTIBODY; CD83 ANTIGEN; CD86 ANTIGEN; CELL SURFACE MARKER; CHEMOKINE RECEPTOR CCR7; CRYSTAL VIOLET; CYTOKINE; FLUORESCEIN ISOTHIOCYANATE; GAMMA INTERFERON; GLYCOPROTEIN P 15095; HLA ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; MESSENGER RNA; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR RELB; TRANSCRIPTION FACTOR T BET; TUMOR NECROSIS FACTOR;

AMASTIGOTE; ARTICLE; BLOOD DONOR; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CELL MATURATION; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INTERNALIZATION; LEISHMANIA DONOVANI; LEISHMANIASIS; OPSONIZATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROMASTIGOTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION; TH1 CELL; UPREGULATION; VISCERAL LEISHMANIASIS;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CRICETINAE; DENDRITIC CELLS; GATA3 TRANSCRIPTION FACTOR; HUMANS; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; LIFE CYCLE STAGES; LYMPHOCYTE ACTIVATION; MESOCRICETUS; MYELOID CELLS; T-BOX DOMAIN PROTEINS; TH1 CELLS;

EID: 33746382602     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/505228     Document Type: Article

References (36)

1. Ho M, Koech DK, Iha DW, Bryceson AD. Immunosuppression in Kenyan visceral leishmaniasis. Clin Exp Immunol 1983; 51:207-14.
2. Gomes NA, Gattass CR, Barreto-De-Souza V, Wilson ME, DosReis GA. TGF-β mediates CTLA-4 suppression of cellular immunity in murine kalaazar. J Immunol 2000; 164:2001-8.
3. Carvalho EM, Teixeira RS, Johnson WD Jr. Cell-mediated immunity in American visceral leishmaniasis: reversible immunosuppression during acute infection. Infect Immun 1981; 33:498-500.
4. Haldar JP, Ghose S, Saha KC, Chose AC. Cell-mediated immune response in Indian kala-azar and post-kala-azar dermal leishmaniasis. Infect Immun 1983; 42:702-7.
5. Harms G, Pedrosa C, Omena S, Feldmeier H, Zwingenberger K. Natural killer cell activity in visceral leishmaniasis. Trans R Soc Trop Med Hyg 1991; 85:54-5.
6. Manna PP, Bharadwaj D, Bhattacharya S, et al. Impairment of natural killer cell activity in Indian kala-azar: restoration of activity by interleukin 2 but not by alpha or gamma Interferon. Infect Immun 1993; 61:3565-9.
7. Rodrigues V Jr, Da Silva JS, Campos-Neto A. Selective inability of spleen antigen presenting cells from Leishmania donovani infected hamsters to mediate specific T cell proliferation to parasite antigens. Parasite Immunol 1992; 14:49-58.
8. Reiner NE. Parasite-accessory cell interactions in murine leishmaniasis. I. Evasion and stimulus-dependent suppression of the macrophage interleukin 1 response by Leishmania donovani. J Immunol 1987; 138: 1919-25.
9. Reiner NE, Ng W, McMaster WR. Parasite-accessory cell interactions in murine leishmaniasis. II. Leishmania donovani suppresses macrophage expression of class I and class II major histocompatibility complex gene products. J Immunol 1987; 138:1926-32.
10. + splenic dendritic cell functions in murine visceral leishmaniasis: correlation with parasite replication in the spleen. Immunology 2000; 99:305-13.
11. Smelt SC, Engwerda CR, McCrossen M, Kaye PM. Destruction of follicular dendritic cells during chronic visceral leishmaniasis. J Immunol 1997; 158:3813-21.
12. Gorak PM, Engwerda CR, Kaye PM. Dendritic cells, but not macrophages, produce IL-12 immediately following Leishmania donovani infection. Eur J Immunol 1998; 28:687-95.
13. Marovich MA, McDowell MA, Thomas EK, Nutman TB. IL-12p70 production by Leishmania major-harboring human dendritic cells is a CD40/CD40 ligand-dependent process. J Immunol 2000; 164:5858-65.
14. Prina E, Abdi SZ, Lebastard M, Perret E, Winter N, Antoine JC. Dendritic cells as host cells for the promastigote and amastigote stages of Leishmania amazonensis: the role of opsonins in parasite uptake and dendritic cell maturation. J Cell Sci 2004; 117:315-25.
15. Quinones M, Ahuja SK, Melby PC, Pate L, Reddick RL, Ahuja SS. Preformed membrane-associated stores of interleukin (IL)-12 are a previously unrecognized source of bioactive IL-12 that is mobilized within minutes of contact with an intracellular parasite. J Exp Med 2000; 192: 507-16.
16. McDowell MA, Marovich M, Lira R, Braun M, Sacks D. Leishmania priming of human dendritic cells for CD40 ligand-induced interleukin-12p70 secretion is strain and species dependent. Infect Immun 2002; 70:3994-4001.
17. + T cells in vivo. J Immunol 2001; 167:4534-42.
18. Amprey JL, Spath GF, Porcelli SA. Inhibition of CD1 expression in human dendritic cells during intracellular infection with Leishmania donovani. Infect Immun 2004; 72:589-92.
19. Von Stebut E, Belkaid Y, Jakob T, Sacks DL, Udey MC. Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin-derived dendritic cells: implications for the initiation of anti-Leishmania immunity. J Exp Med 1998; 188:1547-52.
20. Ghosh AK, Bhattacharya FK, Ghosh DK. Leishmania donovani: amastigote inhibition and mode of action of berberine. Exp Parasitol 1985; 60:404-13.
21. Dey T, Afrin F, Anam K, Ali N. Infectivity and virulence of Leishmania donovani promastigotes: a role for media, source, and strain of parasite. J Eukaryot Microbiol 2002; 49:270-4.
22. Spath GF, Beverley SM. A lipophosphoglycan-independent method for isolation of infective Leishmania metacyclic promastigotes by density gradient centrifugation. Exp Parasitol 2001; 99:97-103.
23. + myeloid dendritic cell subset. J Cell Sci 2004; 117:3435-45.
24. World Health Organization. Control of the leishmaniases: report of a WHO expert committee. World Health Organ Tech Rep Ser 1990; 793: 1-158.
25. Ghosh M, Pal C, Ray M, Maitra S, Mandai L, Bandyopadhyay S. Dendritic cell-based immunotherapy combined with antimony-based chemotherapy cures established murine visceral leishmaniasis. J Immunol 2003; 170:5625-9.
26. Ma JA, Chapman GV, Chen S, Penny R, Breit SN. Flow cytometry with crystal violet to detect intracytoplasmic fluorescence in viable human lymphocytes: demonstration of antibody entering living cells. J Immunol Methods 1987; 104:195-200.
27. Drevets DA, Campbell PA. Macrophage phagocytosis: use of fluorescence microscopy to distinguish between extracellular and intracellular bacteria. J Immunol Methods 1991; 142:31-8.
28. Holzmuller P, Sereno D, Cavaleyra M, et al. Nitric oxide-mediated proteasome-dependent oligonucleosomal DNA fragmentation in Leishmania amazonensis amastigotes. Infect Immun 2002; 70:3727-35.
29. Verma NK, Dey CS. Possible mechanism of miltefosine-mediated death of Leishmania donovani. Antimicrob Agents Chemother 2004; 48:3010-5.
30. Neumann M, Fries H, Scheicher C, et al. Differential expression of Rel/NF-kappaB and octamer factors is a hallmark of the generation and maturation of dendritic cells. Blood 2000; 95:277-85.
31. Alexander J, Bryson K. T helper (h)1/Th2 and Leishmania: paradox rather than paradigm. Immunol Lett 2005; 99:17-23.
32. Szabo SJ, Sullivan BM, Stemmann C, Satoskar AR, Sleckman BP, Glimcher LH. Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science 2002; 295:338-42.
33. Pai SY, Truitt ML, Ho IC. GATA-3 deficiency abrogates the development and maintenance of T helper type 2 cells. Proc Natl Acad Sci USA 2004; 101:1993-8.
34. Woelbing F, Kostka SL, Moelle K, et al. Uptake of Leishmania major by dendritic cells is mediated by Fcγ receptors and facilitates acquisition of protective immunity. J Exp Med 2006; 203:177-8.
35. Ato M, Stager S, Engwerda CR, Kaye PM. Defective CCR7 expression on dendritic cells contributes to the development of visceral leishmaniasis. Nat Immunol 2002; 3:1185-91.
36. Steigerwald M, Moll H. Leishmania major modulates chemokine and chemokine receptor expression by dendritic cells and affects their migratory capacity. Infect Immun 2005; 73:2564-7.